In breast cancer cell lines, RORC was shown to repress TGF-β/EMT-signalling and cancerogenic pathways, which indicates that, also in Cyp51 KO mice, decreased activity of RORC could contribute to increased TGF-β/EMT signalling. This evidence concerns the gene CYP51A1 and breast carcinoma.